# Lisa S. Wang, M.D. – FDA Inspection, Oct 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/lisa-s-wang-md/92b8e960-89e9-442a-8f8c-a4d4dd2d53c1
Source feed: FDA_Inspections

> FDA inspection 1220407 of Lisa S. Wang, M.D., October 13, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220407
- Company Name: Lisa S. Wang, M.D.
- Inspection Date: 2023-10-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Officers

- [Company Rep](https://www.keypedia.com/people/cheron-m-portee/c2cf139d-e4ce-400d-893e-bd733b3ec3a9)
- [Issuing Officer](https://www.keypedia.com/people/grace-p-santos/6f7d8c5d-2044-437b-ac04-a4d63d8a2c5e)
- [Issuing Officer](https://www.keypedia.com/people/jasmine-y-wang/e23c7335-477c-4671-8dcc-72e9149d424e)

Company: https://www.keypedia.com/companies/lisa-s-wang-md/6c75221d-b411-4753-a7d3-877edd39e749

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
